{"432781":{"#nid":"432781","#data":{"type":"event","title":"Integrated Cancer Research Center Seminar","body":[{"value":"\u003Cp\u003E\u003Cstrong\u003E\u0022Comprehensive Prediction of Drug-protein Interactions and Side Effects for the Human Proteome\u0022\u003Cem\u003E\u003Cbr \/\u003E\u003Cbr \/\u003E\u003C\/em\u003EJeffrey Skolnick, Ph.D.\u003Cbr \/\u003E\u003C\/strong\u003E\u003Cstrong\u003EDirector, Center for the Study of Systems Biology\u003Cbr \/\u003E\u003C\/strong\u003E\u003Cstrong\u003EMary and Maisie Gibson Chair \u0026amp; GRA Eminent Scholar in Computational Systems Biology\u003Cbr \/\u003E\u003C\/strong\u003E\u003Cstrong\u003EDirector, Integrative BioSystems Institute\u003Cbr \/\u003E\u003C\/strong\u003E\u003Cstrong\u003EProfessor, School of Biology\u003Cbr \/\u003E\u003C\/strong\u003E\u003Cstrong\u003EGeorgia Tech\u003C\/strong\u003E\u003C\/p\u003E\u003Cp\u003EIdentifying unexpected drug-protein interactions is crucial for drug repurposing. We develop a comprehensive proteome scale approach that predicts human protein targets and side effect of drugs. For drug-protein interaction prediction, FINDSITEcomb, whose average precision is ~30% and recall ~27%, is employed. For side effect prediction, a new method is developed with a precision of ~57% and a recall of ~24%. Our predictions show that drugs are quite promiscuous, with the average (median) number of human targets per drug \u0026nbsp;of 329 (38), while a given protein interacts with 57 drugs. The result implies that drug side effects are inevitable and existing drugs may be useful for repurposing, with only ~1,000 human proteins likely causing serious side effects. A killing index derived from serious side effects has a strong correlation with FDA approved drugs being withdrawn. Therefore, it provides a pre-filter for new drug development. The methodology is free to the academic community on the \u003Ca href=\u0022http:\/\/cssb.biology.gatech.edu\/dr.prodis\/\u0022\u003EDR. PRODIS (DRugome, PROteome, and DISeasome) webserver\u003C\/a\u003E. DR. PRODIS provides protein targets of drugs, drugs for a given protein target, associated diseases and side effects of drugs, as well as an interface for the virtual target screening of new compounds. \u0026nbsp;Successful applications of the methodology to treat Chronic Fatigue Syndrome, to identify novel antibiotic leads and promising anti-seizure drugs are described.\u003C\/p\u003E\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"\u003Cp\u003EGeorgia Tech has been a leader in the development of collaborative approaches to both cancer diagnostics and therapeutics. The mission of the Integrated Cancer Research Center (ICRC) is to facilitate integration of the diversity of technological, computational, scientific and medical expertise at Georgia Tech and partner institutions in a coordinated effort to develop improved cancer diagnostics and therapeutics.\u003C\/p\u003E","format":"limited_html"}],"field_summary_sentence":[{"value":"\u0022Comprehensive Prediction of Drug-protein Interactions and Side Effects for the Human Proteome\u0022 - Jeffrey Skolnick, Ph.D. - Georgia Tech"}],"uid":"27195","created_gmt":"2015-08-10 09:21:05","changed_gmt":"2017-04-13 21:18:53","author":"Colly Mitchell","boilerplate_text":"","field_publication":"","field_article_url":"","field_event_time":{"event_time_start":"2015-10-20T17:00:00-04:00","event_time_end":"2015-10-20T18:00:00-04:00","event_time_end_last":"2015-10-20T18:00:00-04:00","gmt_time_start":"2015-10-20 21:00:00","gmt_time_end":"2015-10-20 22:00:00","gmt_time_end_last":"2015-10-20 22:00:00","rrule":null,"timezone":"America\/New_York"},"extras":[],"hg_media":{"361991":{"id":"361991","type":"image","title":"Integrated Cancer Research Center","body":null,"created":"1449245782","gmt_created":"2015-12-04 16:16:22","changed":"1475895098","gmt_changed":"2016-10-08 02:51:38","alt":"Integrated Cancer Research Center","file":{"fid":"201581","name":"icrc_logo_image_2014-square.jpg","image_path":"\/sites\/default\/files\/images\/icrc_logo_image_2014-square_0.jpg","image_full_path":"http:\/\/www.tlwarc.hg.gatech.edu\/\/sites\/default\/files\/images\/icrc_logo_image_2014-square_0.jpg","mime":"image\/jpeg","size":3173213,"path_740":"http:\/\/www.tlwarc.hg.gatech.edu\/sites\/default\/files\/styles\/740xx_scale\/public\/images\/icrc_logo_image_2014-square_0.jpg?itok=0Vt6IfQ_"}}},"media_ids":["361991"],"related_links":[{"url":"http:\/\/cssb.biology.gatech.edu\/","title":"Center for the Study of Sytems Biology"},{"url":"http:\/\/petitinstitute.gatech.edu\/integrated-cancer-research-center-seminars","title":"ICRC Seminar Series Schedule"}],"groups":[{"id":"1254","name":"Wallace H. Coulter Dept. of Biomedical Engineering"},{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"126221","name":"go-immuno"},{"id":"1808","name":"graduate students"},{"id":"248","name":"IBB"},{"id":"52061","name":"ICRC Seminar"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[{"id":"1795","name":"Seminar\/Lecture\/Colloquium"}],"invited_audience":[{"id":"78751","name":"Undergraduate students"},{"id":"78761","name":"Faculty\/Staff"},{"id":"174045","name":"Graduate students"}],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cp\u003E\u003Ca href=\u0022mailto:john.mcdonald@biology.gatech.edu\u0022\u003EJohn McDonald, Ph.D.\u003C\/a\u003E\u003C\/p\u003E","format":"limited_html"}],"email":[],"slides":[],"orientation":[],"userdata":""}}}